The therapeutic impact is described with the combined use of two medications with different anti-corticosteroid actions in the clinical resolution of a patient with chronic central serous chorioretinopathy.
Anti-corticosteroids combined therapy for treatment of chronic central serous chorioretinopathy
PortesALF. Anti-corticosteroids combined therapy for treatment of chronic central serous chorioretinopathy. Rev Bras Oftalmol. 2018;77(6):369-72.
Portes,André Luís Freire. Anti-corticosteroids combined therapy for treatment of chronic central serous chorioretinopathy. Rev Bras Oftalmol., v. 77, n. 6, p. 369-372, Dec. 2018.
Portes,A.L.F. (2018). Anti-corticosteroids combined therapy for treatment of chronic central serous chorioretinopathy. Rev Bras Oftalmol.,77(6), 369-372.
Portes,André Luís Freire. Anti-corticosteroids combined therapy for treatment of chronic central serous chorioretinopathy. Rev Bras Oftalmol. [online]. 2018, vol. 77, n. 6, [cited 2026-03-08], pp.369-372. Available from: <https://www.rbojournal.org/en/article/anti-corticosteroids-combined-therapy-for-treatment-of-chronic-central-serous-chorioretinopathy/>. ISSN 0034-7280.
